[PDF][PDF] Test-retest reproducibility of extrastriatal dopamine D2 receptor imaging with [123I] epidepride SPECT in humans

A Varrone, M Fujita, NPLG Verhoeff… - Journal of Nuclear …, 2000 - Soc Nuclear Med
MATERIALS AND METHODS Radiolabeling [123I] epidepride was prepared by
iododestannylation from N-[(lethyl-2-pyrrolidinyl)-methyl]-2, 3,-dimethoxy-5-(tributylstannyl) …

Striatal and extrastriatal imaging of dopamine D2 receptors in the living human brain with [123I]epidepride single-photon emission tomography

JT Kuikka, KK Åkerman, J Hiltunen… - European journal of …, 1997 - Springer
The iodine-123 labelled ligand benzamide epidepride was evaluated as a probe for in vivo
imaging of striatal and extrastriatal dopamine D 2 receptor sites in the human brain. Four …

[PDF][PDF] SPECT imaging of dopamine D2 receptors with 2′-iodospiperone

Y Iwasaki, Y Yonekura, H Saji… - Journal of Nuclear …, 1995 - Soc Nuclear Med
SPECT Imaging of Dopamine D2 Receptors with 2â€-lodospiperone Page 1 Departments
ofNuclear Medicüze Brain Pathophysio1o@j', University, Kyoto, Japan Sciences and …

[PDF][PDF] Comparison of iodine-123-epidepride and iodine-123-IBZM for dopamine D2 receptor imaging

WD Leslie, DN Abrams, CR Greenberg… - Journal of Nuclear …, 1996 - Soc Nuclear Med
RESULTS Both radiopharmaceuticals were well tolerated except for minor irritation from the
ethanol vehicle during the 123I-epidepride infusion. Visually, the I23l-epidepride scans pro …

Metabolism of [123I]epidepride may affect brain dopamine D2 receptor imaging with single-photon emission tomography

KA Bergström, M Yu, JT Kuikka, KK Åkerman… - European journal of …, 2000 - Springer
Iodine-123 labelled epidepride is a novel radiopharmaceutical for the study of cerebral
dopamine D 2 receptors using single-photon emission tomography (SPET). A lipophilic …

[PDF][PDF] Dosimetry of iodine-123-epidepride: a dopamine D2 receptor ligand

JR Votaw, MS Ansari, NS Mason… - Journal of Nuclear …, 1995 - Soc Nuclear Med
Dopamine D2 Receptor Ligand Page 1 tive disorders (6) and tardive dyskinesia (7). The
extremely high specificity and affinity of epidepride for the dopamine D2 receptor allows …

[PDF][PDF] Simplified quantification and reproducibility studies of dopamine D2-receptor binding with iodine-123-IBF SPECT in healthy subjects

M Ichise, JR Ballinger, D Vines, S Tsai… - Journal of Nuclear …, 1997 - Soc Nuclear Med
ÖPECT imaging of dopamine D2-receptors using I23l-labeled benzamide analogs such as
[I23l] iodobenzamide (IBZM) and [I23l] iodobenzofuran (IBF) is a potentially useful tool to …

Comparison of three high affinity SPECT radiotracers for the dopamine D2 receptor

MS Al-Tikriti, RM Baldwin, Y Zea-Ponce… - Nuclear medicine and …, 1994 - Elsevier
The regional brain distribution and pharmacological specificity of three high affinity tracers
for the dopamine (DA) D 2 receptor:[123 I] IBF,[123 I] epidepride, and [123 I] 2′-ISP were …

[PDF][PDF] Graphical analysis and simplified quantification of striatal and extrastriatal dopamine D2 receptor binding with [123I] epidepride SPECT

M Ichise, M Fujita, JP Seibyl… - Journal of Nuclear …, 1999 - Soc Nuclear Med
Methods: Multilinear regression analysis (MLRA) and graphical analysis (GA) using plasma
parent (P) plus metabolite (M) activities as input and time activities of receptor-free (RF …

Carbon-11 epidepride: a suitable radioligand for PET investigation of striatal and extrastriatal dopamine D2 receptors

O Langer, C Halldin, F Dollé, CG Swahn… - Nuclear medicine and …, 1999 - Elsevier
Epidepride {(S)-(−)-N-([1-ethyl-2-pyrrolidinyl] methyl)-5-iodo-2, 3-dimethoxybenzamide}
binds with a picomolar affinity (Ki= 24 pM) to the dopamine D2 receptor. Iodine-123-labeled …